Correlation between DLGAP5 expression in pancreatic ductal adenocarcinoma tissue and patient prognosis

Correlation between DLGAP5 expression in pancreatic ductal adenocarcinoma tissue and patient prognosis

Objective To measure the expression of discs large-associated protein 5 (DLGAP5) in pancreatic ductal adenocarcinoma (PDAC) tissue, and to analyze its correlation with clinicopathological features and patient prognosis. Methods A total of 75 patients with PDAC who underwent surgical resection in Qin...

Full description

Saved in:

Bibliographic Details
Main Author:	ZHANG Wenjiao, XIE Fangyu, ZHANG Weiwei, FU Lailin, LYU Mei, LIU Jingyi, HAO Mingxing, XIE Xiangjun
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Precision Medicine 2025-04-01
Series:	精准医学杂志
Subjects:	carcinoma, pancreatic ductal\|adenocarcinoma\|discs large-associated protein 5\|risk factors\|prognosis
Online Access:	https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1745982297688-331411969.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Contribution of gut microbiome to pancreatic ductal adenocarcinoma development
by: D. V. Zaitsev, et al.
Published: (2025-05-01)

Lactate-related lncRNAs assessment model predicts the prognosis of pancreatic ductal adenocarcinoma
by: Jing Sun, et al.
Published: (2025-07-01)

Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Gelu Mihai Breaza, et al.
Published: (2025-03-01)

HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression
by: Aiat Shaban Hemida, et al.
Published: (2024-10-01)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
by: Ritu R. Singh, et al.
Published: (2023-02-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)

Combination of imaging features on pancreatic CT for predicting early recurrence after upfront pancreatoduodenectomy of pancreatic ductal adenocarcinoma
by: Shuanglin Zhang, et al.
Published: (2025-12-01)

Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomic information
by: Kokichi Miyamoto, et al.
Published: (2025-08-01)

Clinical application of combined CT radiomics and clinical features in survival prediction for pancreatic ductal adenocarcinoma patients
by: LI Ke, et al.
Published: (2025-07-01)

Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal adenocarcinoma
by: Keiichiro Kitahama, et al.
Published: (2025-08-01)

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
by: Ryota Matsuki, et al.
Published: (2018-03-01)

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
by: Peiyi Liu, et al.
Published: (2024-11-01)

The Clonal Trajectory of Liver and Lung Metastases in Pancreatic Ductal Adenocarcinoma
by: Ofer N. Gofrit, et al.
Published: (2025-05-01)

PSMD11 and PSMD14 may serve as novel biomarkers for the prognosis of pancreatic ductal adenocarcinoma
by: Yan-Hui Yang, et al.
Published: (2025-03-01)

Neoadjuvant Stereotactic Ablative Radiotherapy in Pancreatic Ductal Adenocarcinoma: A Review of Perioperative and Long-Term Outcomes
by: Robert Michael O’Connell, et al.
Published: (2025-07-01)

Comprehensive analysis of SQOR involvement in ferroptosis resistance of pancreatic ductal adenocarcinoma in hypoxic environments
by: Quan Lin, et al.
Published: (2025-05-01)

Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review
by: Iris Pontón, et al.
Published: (2025-07-01)

Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia
by: D.-Y. Oh, et al.
Published: (2025-06-01)

Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
by: Takuya Mizumoto, et al.
Published: (2017-05-01)

Successful resection of port site recurrence of pancreatic ductal adenocarcinoma after laparoscopic distal pancreatectomy
by: Takashi Aida, et al.
Published: (2023-03-01)

A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma
by: Claire Godier, et al.
Published: (2024-09-01)

Proteomic insights into early pancreatic ductal adenocarcinoma biology and screening
by: Yue Huang, et al.
Published: (2025-08-01)

Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma
by: Zachary Kaplan, et al.
Published: (2025-05-01)

Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment
by: Yuxi Qiao, et al.
Published: (2025-08-01)

A scoring model for preoperative differentiation of high-enhancement pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis
by: Jiaping Zhou, et al.
Published: (2025-07-01)

The supporting role of Schwann cells in perineural invasion of pancreatic ductal adenocarcinoma
by: Yun He, et al.
Published: (2025-06-01)

Identification of SMAD4-mutated pancreatic ductal adenocarcinoma using preoperative contrast-enhanced MRI and clinical characteristics
by: Zhina Li, et al.
Published: (2024-12-01)

Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment
by: Wojciech Ciesielski, et al.
Published: (2024-11-01)

Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma
by: Metoboroghene O. Mowoe, et al.
Published: (2025-01-01)

Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review
by: Ronit Juthani, et al.
Published: (2025-04-01)

Differentiating localized autoimmune pancreatitis and pancreatic ductal adenocarcinoma using endoscopic ultrasound images with deep learning
by: Hitomi Nakamura, et al.
Published: (2024-04-01)

Identification of Tumor‐Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma
by: Chen Zhao, et al.
Published: (2025-06-01)

Raman spectroscopy based diagnosis of pancreatic ductal adenocarcinoma
by: Gianmarco Lazzini, et al.
Published: (2025-04-01)

MORPHOLOGICAL AND EXPRESSION FEATURES OF DUCTAL PANCREATIC ADENOCARCINOMA
by: Yu. Yu. Rakina, et al.
Published: (2017-09-01)

Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma
by: Wenjie Liu, et al.
Published: (2025-04-01)

Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case report
by: Chikanori Tsutsumi, et al.
Published: (2020-07-01)

Lack of association between SLFN11 expression and treatment efficacy or survival outcomes in patients with pancreatic ductal adenocarcinoma
by: Takeaki Nakamura, et al.
Published: (2025-05-01)

CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid‐derived suppressor cells
by: Haitao Gu, et al.
Published: (2021-12-01)